Products for Research Use Only
RegisterLogin

Cisplatin

CAT: 0804-HY-17394-01Size: 5 mgDry Ice: NoHazardous: No
Product image 1
1 / 1
CAT#:0804-HY-17394-01Size:5 mg
Selected
24/48H Stock Items & 2 to 6 Weeks non Stock Items.
Quick Request Actions
Description
Cisplatin (CDDP) is an antineoplastic chemotherapy agent by cross-linking with DNA and causing DNA damage in cancer cells. Cisplatin activates ferroptosis and induces autophagy[1][2][3].
CAS Number
15663-27-1
Product Name Alternative
Cis-Platinum; CDDP; cis-Diaminodichloroplatinum
UNSPSC
12352300
Hazard Statement
H300, H315, H317, H319, H334, H335, H350
Target
Autophagy; DNA Alkylator/Crosslinker; Ferroptosis; Lipoxygenase; Pyroptosis
Type
Reference compound
Related Pathways
Apoptosis; Autophagy; Cell Cycle/DNA Damage; Immunology/Inflammation; Metabolic Enzyme/Protease
Applications
Cancer-programmed cell death
Field of Research
Cancer
Assay Protocol
https://www.medchemexpress.com/Cisplatin.html
Purity
99.95
Solubility
DMF : 10 mg/mL (ultrasonic; warming; heat to 60°C) |DMSO : ≥ 300 mg/mL|H2O : 1 mg/mL (ultrasonic; warming; heat to 60°C)
Smiles
Cl[Pt](Cl)([NH3])[NH3]
Molecular Formula
Cl2H6N2Pt
Molecular Weight
300.05
Precautions
H300, H315, H317, H319, H334, H335, H350
References & Citations
[1]Wang X, et al. Requirement for ERK activation in cisplatin-induced apoptosis. J Biol Chem. 2000 Dec 15;275 (50) :39435-43.|[2]Cummings BS, et al. Cisplatin-induced renal cell apoptosis: caspase 3-dependent and -independent pathways. J Pharmacol Exp Ther. 2002 Jul;302 (1) :8-17.|[3]Park HR, et al. Enhanced antitumor efficacy of cisplatin in combination with HemoHIM in tumor-bearing mice. BMC Cancer. 2009 Mar 17;9:85.|[4]Shimeda Y, et al. Protective effects of capsaicin against cisplatin-induced nephrotoxicity in rats. Biol Pharm Bull. 2005 Sep;28 (9) :1635-8.|[5]Hall MD, et al. Say no to DMSO: dimethylsulfoxide inactivates cisplatin, NSC 241240, and other platinum complexes. Cancer Res. 2014 Jul 15;74 (14) :3913-22.|[6]Wu K, et al. Cisplatin inhibits the progression of bladder cancer by selectively depleting G-MDSCs: A novel chemoimmunomodulating strategy. Clin Immunol. 2018 Aug;193:60-69.|[7]Noha Alassaf, et al. Autophagy and necroptosis in cisplatin-induced acute kidney injury: Recent advances regarding their role and therapeutic potential. Front Pharmacol. 2023 Jan 30:14:1103062. |[8]Ryan M Williams, et al. Kidney-Targeted Redox Scavenger Therapy Prevents Cisplatin-Induced Acute Kidney Injury. Front Pharmacol. 2022 Jan 3:12:790913.
Shipping Conditions
Room Temperature
Storage Conditions
4°C (Powder, protect from light)
Scientific Category
Reference compound1
Clinical Information
Launched

Alternative Products

CatalogName
A8321-500Cisplatin

Popular Products